REG - One Health Group PLC - AGM Statement

One HealthAnnouncement

Yesterday 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250912:nRSL0241Za&default-theme=true

RNS Number : 0241Z  One Health Group PLC  12 September 2025

One Health Group plc

("One Health", the "Company" or the "Group")

 

AGM Statement

 

Positive trading year to date in line with management expectations

 

One Health Group plc (AIM: OHGR), an independent provider of NHS-funded
medical procedures, for patients referred through 'Patient Choice' for
treatment in Orthopaedics, Spine, General Surgery, Gynaecology and Urology,
provides an update on its trading year to date, ahead of its Annual General
Meeting ('AGM') taking place today at 11.00 a.m. at 131 Psalter Lane,
Sheffield S11 8UX.

 

Derek Bickerstaff, Chair, will provide the following statement at the AGM:

 

"I am very pleased to announce that trading in the early part of the year
ending 31 March 2026 ("FY 2026") remains strong and in-line with management
expectations.

 

"The business continues to deliver strong organic growth, and we are making
good progress to supplement this with additional strategic growth via the
development of a network of surgical hubs. In the summer we announced that the
planning application for our first Surgical Hub in Scunthorpe, Lincolnshire,
was granted. We have since completed the acquisition of the land and appointed
an experienced contractor to oversee the build. Preparation of the site for
construction is underway, and we remain confident of operational readiness
within 12 months of construction commencement. We will update shareholders as
the project progresses.

 

"The Company continues to provide care, free at the point of delivery to more
NHS patients through 'Patient Choice' across an ever-increasing geography to
reduce the pressure on waiting lists. We look forward to providing a further
update on trading for the six months ending 30 September 2025 in late
October."

 

For more information, please contact:

 

 One Health Group plc                                                                                                www.onehealth.co.uk/investors (http://www.onehealth.co.uk/investors)

 Derek Bickerstaff, Chairman                                                                                         Via Walbrook PR

 Adam Binns, CEO

 Panmure Liberum (Nominated Adviser and Broker)                                                                      Tel: +44 (0)20 3100 2000

 Emma Earl, Will Goode, Mark Rogers

 Rupert Dearden

 Walbrook PR (Media & Investor Relations)      Tel: +44 (0)20 7933 8780 or onehealth@walbrookpr.com

                                             (mailto:onehealth@walbrookpr.com)
 Alice Woodings / Paul McManus /

                                             Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893 /
 Rachel Broad

                                               +44 (0)7747 515 393

 

About One Health Group plc (www.onehealth.co.uk (http://www.onehealth.co.uk) )

One Health engages 80 NHS Consultants (excluding anaesthetists) who
sub-specialise in the various surgeries offered by the Company, through a
growing network of community-based outreach clinics and surgical operating
locations. One Health continues to deliver strong growth and, in the year, to
March 2025 provided much needed care to 17,020 new patients, through over
42,000 consultations and over 7,000 surgical procedures. One Health deploys
surgeons and anaesthetists that are mostly employed by the NHS, on a
subcontracted basis. It currently works with over 100 professionals across 9
independent hospitals and 37 outreach clinics. Within these community-based
outreach clinics all consultations and post operative physiotherapy is
delivered where required, reducing patient inconvenience and excess travel.

 

One Health's activities are focused on areas where NHS patient needs are
under-supplied by the local NHS service, population density is relatively high
and the level of private medical insurance or the ability to self-fund is
relatively low. Currently, the Company's activities are focused in Yorkshire,
Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue is
derived from over 60 NHS commissioning bodies in addition to contracts with
local NHS Hospital Trusts to transfer their internal waiting list patients to
One Health for quicker treatment.

 

One Health's business model has focused to date on four main areas:
orthopaedics, spine, general surgery and gynaecology, with urology introduced
at the end of FY25.

 

Spine and orthopaedics are particularly attractive areas for One Health as the
Directors believe that they benefit from powerful growth drivers in terms of
an ageing demographic, physical inactivity and an increasing proportion of the
population being categorised as obese. Within orthopaedics, the most common
surgeries performed by One Health are knee and hip replacements.

 

Online investor presentation

Listen here for on online presentation by Derek Bickerstaff, Chairman and Adam
Binns, Chief Executive Officer, following the announcement of their most
recent financial results which offer insights into the Company's growth
strategy and long-term vision:

 

https://sparklive.lseg.com/ONEHEALTHGROUP/events/d0e32595-a4a2-4379-a646-7da97431a300/one-health-group-investor-event-and-full-year-results-announcement-for-2025
(https://sparklive.lseg.com/ONEHEALTHGROUP/events/d0e32595-a4a2-4379-a646-7da97431a300/one-health-group-investor-event-and-full-year-results-announcement-for-2025)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AGMSFDFIFEISEFU